Vanguard Group’s 4D Molecular Therapeutics FDMT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10.2M | Sell |
2,736,671
-20,819
| -0.8% | -$77.2K | ﹤0.01% | 2892 |
|
|
2025
Q1 | $8.91M | Sell |
2,757,490
-103,018
| -4% | -$333K | ﹤0.01% | 2907 |
|
|
2024
Q4 | $15.9M | Buy |
2,860,508
+92,791
| +3% | +$517K | ﹤0.01% | 2694 |
|
|
2024
Q3 | $29.9M | Buy |
2,767,717
+239,537
| +9% | +$2.59M | ﹤0.01% | 2402 |
|
|
2024
Q2 | $53.1M | Buy |
2,528,180
+188,237
| +8% | +$3.95M | ﹤0.01% | 2121 |
|
|
2024
Q1 | $74.6M | Buy |
2,339,943
+473,094
| +25% | +$15.1M | ﹤0.01% | 2006 |
|
|
2023
Q4 | $37.8M | Sell |
1,866,849
-35,618
| -2% | -$722K | ﹤0.01% | 2304 |
|
|
2023
Q3 | $24.2M | Sell |
1,902,467
-70,635
| -4% | -$899K | ﹤0.01% | 2472 |
|
|
2023
Q2 | $35.7M | Buy |
1,973,102
+427,218
| +28% | +$7.72M | ﹤0.01% | 2345 |
|
|
2023
Q1 | $26.6M | Buy |
1,545,884
+273,674
| +22% | +$4.7M | ﹤0.01% | 2461 |
|
|
2022
Q4 | $28.3M | Sell |
1,272,210
-48,152
| -4% | -$1.07M | ﹤0.01% | 2468 |
|
|
2022
Q3 | $10.6M | Sell |
1,320,362
-1,787
| -0.1% | -$14.4K | ﹤0.01% | 2933 |
|
|
2022
Q2 | $9.23M | Buy |
1,322,149
+31,208
| +2% | +$218K | ﹤0.01% | 3038 |
|
|
2022
Q1 | $19.5M | Buy |
1,290,941
+7,858
| +0.6% | +$119K | ﹤0.01% | 2790 |
|
|
2021
Q4 | $28.2M | Buy |
1,283,083
+337,106
| +36% | +$7.4M | ﹤0.01% | 2662 |
|
|
2021
Q3 | $25.5M | Buy |
945,977
+475,701
| +101% | +$12.8M | ﹤0.01% | 2714 |
|
|
2021
Q2 | $11.3M | Buy |
470,276
+33,014
| +8% | +$795K | ﹤0.01% | 3136 |
|
|
2021
Q1 | $19M | Buy |
437,262
+427,262
| +4,273% | +$18.5M | ﹤0.01% | 2809 |
|
|
2020
Q4 | $414K | Buy |
+10,000
| New | +$414K | ﹤0.01% | 3993 |
|